393 related articles for article (PubMed ID: 25810523)
1. MuSK frizzled-like domain is critical for mammalian neuromuscular junction formation and maintenance.
Messéant J; Dobbertin A; Girard E; Delers P; Manuel M; Mangione F; Schmitt A; Le Denmat D; Molgó J; Zytnicki D; Schaeffer L; Legay C; Strochlic L
J Neurosci; 2015 Mar; 35(12):4926-41. PubMed ID: 25810523
[TBL] [Abstract][Full Text] [Related]
2. Dok-7/MuSK signaling and a congenital myasthenic syndrome.
Yamanashi Y; Higuch O; Beeson D
Acta Myol; 2008 Jul; 27(1):25-9. PubMed ID: 19108574
[TBL] [Abstract][Full Text] [Related]
3. A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions.
Chevessier F; Girard E; Molgó J; Bartling S; Koenig J; Hantaï D; Witzemann V
Hum Mol Genet; 2008 Nov; 17(22):3577-95. PubMed ID: 18718936
[TBL] [Abstract][Full Text] [Related]
4. Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis.
Ohno K; Ito M; Kawakami Y; Krejci E; Engel AG
Chem Biol Interact; 2013 Mar; 203(1):335-40. PubMed ID: 22981737
[TBL] [Abstract][Full Text] [Related]
5. The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.
Tezuka T; Inoue A; Hoshi T; Weatherbee SD; Burgess RW; Ueta R; Yamanashi Y
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16556-61. PubMed ID: 25368159
[TBL] [Abstract][Full Text] [Related]
6. Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure.
Rodríguez Cruz PM; Cossins J; Cheung J; Maxwell S; Jayawant S; Herbst R; Waithe D; Kornev AP; Palace J; Beeson D
Hum Mutat; 2020 Mar; 41(3):619-631. PubMed ID: 31765060
[TBL] [Abstract][Full Text] [Related]
7. A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia.
Ben Ammar A; Soltanzadeh P; Bauché S; Richard P; Goillot E; Herbst R; Gaudon K; Huzé C; Schaeffer L; Yamanashi Y; Higuchi O; Taly A; Koenig J; Leroy JP; Hentati F; Najmabadi H; Kahrizi K; Ilkhani M; Fardeau M; Eymard B; Hantaï D
PLoS One; 2013; 8(1):e53826. PubMed ID: 23326516
[TBL] [Abstract][Full Text] [Related]
8. Developmental consequences of the ColQ/MuSK interactions.
Karmouch J; Dobbertin A; Sigoillot S; Legay C
Chem Biol Interact; 2013 Mar; 203(1):287-91. PubMed ID: 23089045
[TBL] [Abstract][Full Text] [Related]
9. ColQ controls postsynaptic differentiation at the neuromuscular junction.
Sigoillot SM; Bourgeois F; Lambergeon M; Strochlic L; Legay C
J Neurosci; 2010 Jan; 30(1):13-23. PubMed ID: 20053883
[TBL] [Abstract][Full Text] [Related]
10. [Pathophysiological characterization of congenital myasthenic syndromes: the example of mutations in the MUSK gene].
Chevessier F; Faraut B; Ravel-Chapuis A; Richard P; Gaudon K; Bauché S; Prioleau C; Herbst R; Goillot E; Ioos C; Azulay JP; Attarian S; Leroy JP; Fournier E; Legay C; Schaeffer L; Koenig J; Fardeau M; Eymard B; Pouget J; Hantaï D
J Soc Biol; 2005; 199(1):61-77. PubMed ID: 16114265
[TBL] [Abstract][Full Text] [Related]
11. Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis.
Huijbers MG; Plomp JJ; van Es IE; Fillié-Grijpma YE; Kamar-Al Majidi S; Ulrichts P; de Haard H; Hofman E; van der Maarel SM; Verschuuren JJ
Exp Neurol; 2019 Jul; 317():133-143. PubMed ID: 30851266
[TBL] [Abstract][Full Text] [Related]
12. MuSK signaling at the neuromuscular junction.
Wang Q; Zhang B; Xiong WC; Mei L
J Mol Neurosci; 2006; 30(1-2):223-6. PubMed ID: 17192681
[TBL] [Abstract][Full Text] [Related]
13. Wnt4 participates in the formation of vertebrate neuromuscular junction.
Strochlic L; Falk J; Goillot E; Sigoillot S; Bourgeois F; Delers P; Rouvière J; Swain A; Castellani V; Schaeffer L; Legay C
PLoS One; 2012; 7(1):e29976. PubMed ID: 22253844
[TBL] [Abstract][Full Text] [Related]
14. Schwann Cells in Neuromuscular Junction Formation and Maintenance.
Barik A; Li L; Sathyamurthy A; Xiong WC; Mei L
J Neurosci; 2016 Sep; 36(38):9770-81. PubMed ID: 27656017
[TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanisms underlying the formation of neuromuscular junction].
Higuchi O; Yamanashi Y
Brain Nerve; 2011 Jul; 63(7):649-55. PubMed ID: 21747134
[TBL] [Abstract][Full Text] [Related]
16. Synapse disassembly and formation of new synapses in postnatal muscle upon conditional inactivation of MuSK.
Hesser BA; Henschel O; Witzemann V
Mol Cell Neurosci; 2006 Mar; 31(3):470-80. PubMed ID: 16337809
[TBL] [Abstract][Full Text] [Related]
17. Implication of geranylgeranyltransferase I in synapse formation.
Luo ZG; Je HS; Wang Q; Yang F; Dobbins GC; Yang ZH; Xiong WC; Lu B; Mei L
Neuron; 2003 Nov; 40(4):703-17. PubMed ID: 14622576
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction.
Nakata T; Ito M; Azuma Y; Otsuka K; Noguchi Y; Komaki H; Okumura A; Shiraishi K; Masuda A; Natsume J; Kojima S; Ohno K
Hum Mutat; 2013 Jul; 34(7):997-1004. PubMed ID: 23553736
[TBL] [Abstract][Full Text] [Related]
19. Collagen Q is a key player for developing rational therapy for congenital myasthenia and for dissecting the mechanisms of anti-MuSK myasthenia gravis.
Ohno K; Ito M; Kawakami Y; Ohtsuka K
J Mol Neurosci; 2014 Jul; 53(3):359-61. PubMed ID: 24234034
[TBL] [Abstract][Full Text] [Related]
20. LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.
Ohkawara B; Cabrera-Serrano M; Nakata T; Milone M; Asai N; Ito K; Ito M; Masuda A; Ito Y; Engel AG; Ohno K
Hum Mol Genet; 2014 Apr; 23(7):1856-68. PubMed ID: 24234652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
